Literature DB >> 24337519

Involuntary movement in pediatric moyamoya disease patients: consideration of pathogenetic mechanism using neuroimaging studies.

Ji Yeoun Lee1, Seung-Ki Kim, Kyu-Chang Wang, Jong Hee Chae, Jung-Eun Cheon, Jung Won Choi, Ji Hoon Phi, Byung Chan Lim, Ki Joong Kim, In-One Kim, Yong Seung Hwang, Young Seob Chung.   

Abstract

PURPOSE: Involuntary movement is a rare symptom of moyamoya disease (MMD). No consensus has been reached regarding its clinical features and pathogenetic mechanism. Therefore, pediatric MMD patients presenting with involuntary movement were retrospectively analyzed, focusing on the image findings.
METHODS: A total of 513 patients who were treated for MMD were reviewed. After exclusion of MMD syndromes and those with accompanying conditions related to involuntary movements, five patients (mean age: 11.6 years, range: 5-13 years) were evaluated.
RESULTS: All of the patients improved their symptoms rapidly after the indirect bypass operations to the contralateral hemisphere. All remained symptom-free during the long follow-up period. Comprehensive evaluation of the preoperative imaging findings failed to suggest a characteristic feature in common, corresponding to the existing hypotheses or a new hypothesis. Only one patient showed infarction preoperatively, and only one patient showed prominently enhanced collateral vessels in the basal ganglia. Although a decrease in vascular reserve was observed in all patients, the location and laterality were nonspecific.
CONCLUSION: There still appears to be confusion regarding the pathogenetic mechanism of involuntary movement in MMD with no repetitive, established imaging features to explain the phenomenon. Nonetheless, with its excellent response to surgical treatment, clinical awareness of this rare symptom of MMD should be emphasized as a differential diagnosis for secondary movement disorder in children.

Entities:  

Mesh:

Year:  2013        PMID: 24337519     DOI: 10.1007/s00381-013-2339-6

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  20 in total

Review 1.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

2.  Posterior cerebral artery involvement in moyamoya disease: initial infarction and angle between PCA and basilar artery.

Authors:  Ji Yeoun Lee; Seung-Ki Kim; Jung-Eun Cheon; Jung Won Choi; Ji Hoon Phi; In-One Kim; Byung-Kyu Cho; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2013-05-08       Impact factor: 1.475

Review 3.  Classification of movement disorders.

Authors:  Stanley Fahn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 4.  Movement disorders associated with moyamoya disease: a report of 4 new cases and a review of literatures.

Authors:  Jong Sam Baik; Myung Sik Lee
Journal:  Mov Disord       Date:  2010-07-30       Impact factor: 10.338

5.  Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease.

Authors:  Seung-Ki Kim; Kyu-Chang Wang; In-One Kim; Dong Soo Lee; Byung-Kyu Cho
Journal:  Neurosurgery       Date:  2002-01       Impact factor: 4.654

6.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

7.  Dramatic disappearance of moyamoya disease-induced chorea after indirect bypass surgery.

Authors:  Koji Kamijo; Toru Matsui
Journal:  Neurol Med Chir (Tokyo)       Date:  2008-09       Impact factor: 1.742

8.  Moyamoya-induced paroxysmal dyskinesia.

Authors:  Pedro Gonzalez-Alegre; Zakaria Ammache; Patricia H Davis; Robert L Rodnitzky
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

Review 9.  Movement disorders in cerebrovascular disease.

Authors:  Raja Mehanna; Joseph Jankovic
Journal:  Lancet Neurol       Date:  2013-04-19       Impact factor: 44.182

10.  Clinical features of moyamoya disease in the United States.

Authors:  D Chiu; P Shedden; P Bratina; J C Grotta
Journal:  Stroke       Date:  1998-07       Impact factor: 7.914

View more
  4 in total

Review 1.  Movement Disorders Following Cerebrovascular Lesions: Etiology, Treatment Options and Prognosis.

Authors:  Do-Young Kwon
Journal:  J Mov Disord       Date:  2016-05-25

2.  Oro-mandibular dystonia in pediatric moyamoya disease: Two cases report.

Authors:  Yuichiro Koga; Daina Kashiwazaki; Emiko Hori; Naoki Akioka; Satoshi Kuroda
Journal:  Surg Neurol Int       Date:  2021-09-06

3.  Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort.

Authors:  Chiara Po'; Margherita Nosadini; Marialuisa Zedde; Rosario Pascarella; Giuseppe Mirone; Domenico Cicala; Anna Rosati; Alessandra Cosi; Irene Toldo; Raffaella Colombatti; Paola Martelli; Alessandro Iodice; Patrizia Accorsi; Lucio Giordano; Salvatore Savasta; Thomas Foiadelli; Giuseppina Sanfilippo; Elvis Lafe; Federico Zappoli Thyrion; Gabriele Polonara; Serena Campa; Federico Raviglione; Barbara Scelsa; Stefania Maria Bova; Filippo Greco; Duccio Maria Cordelli; Luigi Cirillo; Francesco Toni; Valentina Baro; Francesco Causin; Anna Chiara Frigo; Agnese Suppiej; Laura Sainati; Danila Azzolina; Manuela Agostini; Elisabetta Cesaroni; Luigi De Carlo; Gabriella Di Rosa; Giacomo Esposito; Luisa Grazian; Giovanna Morini; Francesco Nicita; Francesca Felicia Operto; Dario Pruna; Paola Ragazzi; Massimo Rollo; Alberto Spalice; Pasquale Striano; Aldo Skabar; Luigi Alberto Lanterna; Andrea Carai; Carlo Efisio Marras; Renzo Manara; Stefano Sartori
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.418

4.  Movement Disorders Associated With Cerebral Artery Stenosis: A Nationwide Study.

Authors:  Kye Won Park; Nari Choi; Eungseok Oh; Chul Hyoung Lyoo; Min Seok Baek; Han-Joon Kim; Dalla Yoo; Jee-Young Lee; Ji-Hyun Choi; Jae Hyeok Lee; Seong-Beom Koh; Young Hee Sung; Jin Whan Cho; Hui-Jun Yang; Jinse Park; Hae-Won Shin; Tae-Beom Ahn; Ho-Sung Ryu; Sooyeoun You; Seong-Min Choi; Bum Joon Kim; Seung Hyun Lee; Sun Ju Chung
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.